Comparison of outcome of all inside anterior cruciate ligament reconstruction using semitendinosus autograft with and without augmentation, A prospective randomized control trial.â??

â??Comparison of outcome of anterior cruciate ligament reconstruction using hamstring autograft with and without augmentation, A prospective randomized control trial.â??

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023928

Enrollment

Registered

2020-03-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M235- Chronic instability of knee

Interventions

Intervention1: All inside anterior cruciate ligament reconstruction using semitendinosus autograft with augmentation.: Standard and described surgical procedure will be followed for anterior cruicia

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA: a) Isolated complete ACL tear b) ACL deficient Patients having symptom of instability or giving way of the involved knee. c) Patient age 16-40 year d) No radiological arthritic changes in affected knee. e) Patient willing to participate in study.

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA- a) ACL injury associated with other collateral ligament and posterior cruciate ligament injury. b) Asymptomatic ACL deficient patients c) Age less than 16 year or more than 40 year. d) Radiological arthritic changes in affected knee. e) Patient refused to participate in study f) Any prior surgery in ipsilateral knee.

Design outcomes

Primary

Measure	Time frame
â?¢ Pain ( visual analogue scale) â?¢ Lysholm functional knee score â?¢ Tegner activity scale â?¢ KT 1000 arthrometer laxity measurements â?¢ Subjective examination {Lachmen test, Anterior drawer test, Pivot shift test} Timepoint: SIX MONTHS AFTER THE SURGERY	—

Secondary

Measure	Time frame
PROTECTIVE EFFECT OF AUGMENTATIONTimepoint: Post operatively patient will be followed up at 2, 4 and 6 months	—

Countries

India

Contacts

Public ContactSIDDHARTH JAIN

AIIMS , NEW DELHI

hlnag2003@yahoo.co.in01126593341

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026